Tirzepatide does more than just reduce appetite: it simultaneously acts on three vital organs to combat obesity and type 2 diabetes. Tirzepatide, the active ingredient in Mounjaro and Zepbound, is often presented as a simple injectable appetite suppressant. This reductive view ignores the complexity of its mechanism of action. In reality, this … Read more
From Mediator to Fen-Phen and rimonabant: the history of anti-obesity treatments and why GLP-1s represent a revolution.
A comprehensive overview of GLP-1 agonists available in France in 2026: Mounjaro, Ozempic, Wegovy, Trulicity. Comparison, reimbursement, and future molecules.
GIP receptors are the key differentiating factor for Mounjaro. Their role in adipose tissue, the brain, and bones explains the superiority of tirzepatide.
Tirzepatide Half-Life: How 3 Chemical Modifications Transform a 3-Minute Hormone into a Weekly Treatment. Pharmacokinetics Explained.
How tirzepatide reduces appetite: mechanisms of satiety, food noise, neuronal signals. What patients experience and how to optimize.
Zepbound and Mounjaro contain the same tirzepatide. What are the differences? Indications, reimbursement, availability in France. All you need to know in 2026.
Mounjaro vs Wegovy: complete 2026 comparison. Weight loss, side effects, cardiovascular benefits, cost. Which one to choose based on your profile?
Mounjaro vs Ozempic: A comprehensive comparison of the two GLP-1 treatments. Efficacy, side effects, price, and selection criteria based on clinical studies.
GLP-1 and GIP: discover the role of these two incretin hormones targeted by tirzepatide (Mounjaro). Mechanisms of action, differences, and synergy for weight loss.
Discover the unique mechanism of action of tirzepatide, the first dual GIP/GLP-1 agonist. Learn how Mounjaro acts on the brain, pancreas, liver, and adipose tissue to produce superior weight loss compared to mono-agonists.